Table of Contents Author Guidelines Submit a Manuscript
Biochemistry Research International
Volume 2012, Article ID 832059, 10 pages
http://dx.doi.org/10.1155/2012/832059
Research Article

Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer Cells

Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0596, USA

Received 3 April 2012; Accepted 10 May 2012

Academic Editor: Eun-Kyoung Yim Breuer

Copyright © 2012 Eleftheria Tsakalozou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [32 citations]

The following is the list of published articles that have cited the current article.

  • Vishwesh Patil, Keyur Gada, Rajiv Panwar, Stan Majewski, Yared Tekabe, Alexandra Varvarigou, and Ban-An Khaw, “In vitro demonstration of enhanced prostate cancer toxicity: pretargeting with Bombesin bispecific complexes and targeting with polymer-drug-conjugates,” Journal of Drug Targeting, vol. 21, no. 10, pp. 1012–1021, 2013. View at Publisher · View at Google Scholar
  • Mohamed M. Rafi, Saravanan Kanakasabai, and Marynell D. Reyes, “Lycopene modulates growth and survival associated genes in prostate cancer,” Journal of Nutritional Biochemistry, vol. 24, no. 10, pp. 1724–1734, 2013. View at Publisher · View at Google Scholar
  • Mohamed M. Rafi, Saravanan Kanakasabai, Sarita V. Gokarn, Eric G. Krueger, and John J. Bright, “Dietary Lutein Modulates Growth and Survival Genes in Prostate Cancer Cells,” Journal of Medicinal Food, pp. 140827134557001, 2014. View at Publisher · View at Google Scholar
  • Zahra Hami, Mohsen Amini, Mahmoud Ghazi-Khansari, Seyed Mehdi Rezayat, and Kambiz Gilani, “Synthesis and in vitro evaluation of a pH-sensitive PLA-PEG-Folate based polymeric micelle for controlled delivery of docetaxel,” Colloids and Surfaces B: Biointerfaces, 2014. View at Publisher · View at Google Scholar
  • Majid Tafrihi, Samane Toosi, Tayebeh Minaei, Ahmad Reza Gohari, and Vahid Niknam, “Anticancer Properties of Teucrium persicum in PC-3 Prostate Cancer Cells,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 2, pp. 785–791, 2014. View at Publisher · View at Google Scholar
  • Rajab, Mohd Nazip, Florinsiah, Norfazlina, Farida Zuraina, Rumiza, Suziana Zaila, Lek Mun, and Nurshahirah, “In vitro cytotoxicity effects of single and combination Nigella sativa and Zingiber zerumbet extracts on human myeloid leukemia (HL60) cells and its mode of cell death,” Journal of Applied Pharmaceutical Science, vol. 4, no. 5, pp. 51–55, 2014. View at Publisher · View at Google Scholar
  • Seok-Cheol Cho, and Bu Young Choi, “Resveratrol prevents hormone-refractory prostate cancer cell growth via inhibition of STAT3 activity,” Korean Journal of Food Science and Technology, vol. 46, no. 4, pp. 516–521, 2014. View at Publisher · View at Google Scholar
  • Kaisar Raza, Nagarani Thotakura, Pramod Kumar, Mayank Joshi, Shashi Bhushan, Amit Bhatia, Vipin Kumar, Ruchi Malik, Gajanand Sharma, Santosh Kumar Guru, and O.P. Katare, “C60-Fullerenes for Delivery of Docetaxel to Breast Cancer Cells: A Promising Approach for Enhanced Efficacy and Better Pharmacokinetic Profile,” International Journal of Pharmaceutics, 2015. View at Publisher · View at Google Scholar
  • Yao Liu, Xuan Zhang, Chunhong Liu, Ruili Yang, Zhenlin Xu, Lijun Zhou, Yuanming Sun, and Hongtao Lei, “Enantioselective and synergetic toxicity of axial chiral herbicide propisochlor to SP2/0 myeloma cell,” Journal of Agricultural and Food Chemistry, pp. 150824075844002, 2015. View at Publisher · View at Google Scholar
  • Ariane Chan, A. Jonathan Singh, Peter T. Northcote, and John H. Miller, “Inhibition of human vascular endothelial cell migration and capillary-like tube formation by the microtubule-stabilizing agent peloruside A,” Investigational New Drugs, 2015. View at Publisher · View at Google Scholar
  • Mun Juinn Chow, Maria V. Babak, Daniel Yuan Qiang Wong, Giorgia Pastorin, Christian Gaiddon, and Wee Han Ang, “Structural Determinants of p53-Independence in Anticancer Ruthenium-Arene Schiff-Base Complexes,” Molecular Pharmaceutics, 2016. View at Publisher · View at Google Scholar
  • Ming-Thau Sheu, Hua-Jing Jhan, Chia-Yu Su, Ling-Chun Chen, Chia-En Chang, Der-Zen Liu, and Hsiu-O Ho, “Codelivery of doxorubicin-containing thermosensitive hydrogels incorporated with docetaxel-loaded mixed micelles enhances local cancer therapy,” Colloids and Surfaces B: Biointerfaces, 2016. View at Publisher · View at Google Scholar
  • Subhajit Ghosh, Saswat Mohapatra, Anisha Thomas, Debmalya Bhunia, Abhijit Saha, Gaurav Das, Batakrishna Jana, and Surajit Ghosh, “Apoferritin-nanocage delivers combination of microtubule and nucleus targeting anticancer drugs,” ACS Applied Materials & Interfaces, 2016. View at Publisher · View at Google Scholar
  • Henk A. Van Veen, Sumit Lal, Cornelis J.F. Van Noorden, and Jyoti Verma, “Delivery and cytotoxicity of doxorubicin and temozolomide to primary glioblastoma cells using gold nanospheres and gold nanorods,” European Journal of Nanomedicine, vol. 8, no. 1, pp. 49–60, 2016. View at Publisher · View at Google Scholar
  • Nahid Shahabadi, Monireh Falsafi, Foroozan Feizi, and Reza Khodarahmi, “ Functionalization of γ-Fe 2 O 3 @SiO 2 nanoparticles using the antiviral drug zidovudine: synthesis, characterization, in vitro cytotoxicity and DNA interaction studies ,” RSC Adv., vol. 6, no. 77, pp. 73605–73616, 2016. View at Publisher · View at Google Scholar
  • Aleksandra Božić, Aleksandar Marinković, Snežana Bjelogrlić, Tamara R. Todorović, Ilija N. Cvijetić, Irena Novaković, Christian D. Muller, and Nenad R. Filipović, “Quinoline based mono- and bis-(thio)carbohydrazones: synthesis, anticancer activity in 2D and 3D cancer and cancer stem cell models,” RSC Adv., vol. 6, no. 106, pp. 104763–104781, 2016. View at Publisher · View at Google Scholar
  • Maya Sreeranganathan, Saji Uthaman, In-Kyu Park, Bruno Sarmento, Chethampadi Gopi Mohan, and Rangasamy Jayakumar, “In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts,” International Journal of Nanomedicine, vol. 12, pp. 7167–7182, 2017. View at Publisher · View at Google Scholar
  • Xiaoran Li, Jie Lu, Quancheng Kan, Xiaoli Li, Qiong Fan, Yaqing Li, Ruixia Huang, Ana Slipicevic, Hiep Phuc Dong, Lars Eide, Junbai Wang, Hongquan Zhang, Viktor Berge, Mariusz Adam Goscinski, Gunnar Kvalheim, Jahn M. Nesland, and Zhenhe Suo, “Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Juan Carlos Gallardo-P?rez, Alhel? Ad?n-Ladr?n de Guevara, Alvaro Mar?n-Hern?ndez, Rafael Moreno-S?nchez, and Sara Rodr?guez-Enr?quez, “HPI/AMF inhibition halts the development of the aggressive phenotype of breast cancer stem cells,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2017. View at Publisher · View at Google Scholar
  • Zeynep N. Erdem, Stefanie Schwarz, Daniel Drev, Christine Heinzle, Andrea Reti, Petra Heffeter, Xenia Hudec, Klaus Holzmann, Bettina Grasl-Kraupp, Walter Berger, Michael Grusch, and Brigitte Marian, “Irinotecan Upregulates Fibroblast Growth Factor Receptor 3 Expression in Colorectal Cancer Cells, Which Mitigates Irinotecan-Induced Apoptosis,” Translational Oncology, vol. 10, no. 3, pp. 332–339, 2017. View at Publisher · View at Google Scholar
  • Miyuki Mabuchi, Akito Tanaka, Masahiro Ueda, Yuri Yoshida, Kota Horiike, Kenta Yamaoka, Syuhei Nakao, Tadashi Shimizu, Yuko Ueda, and Kazutake Tsujikawa, “Systematic trial for evaluating docetaxel in a human prostate cancer cell DU145 xenograft model,” Anticancer Research, vol. 37, no. 4, pp. 1665–1676, 2017. View at Publisher · View at Google Scholar
  • Seon Young Choi, Hang-Rae Kim, Pan Dong Ryu, and So Yeong Lee, “Regulation of voltage-gated potassium channels attenuates resistance of side-population cells to gefitinib in the human lung cancer cell line NCI-H460,” BMC Pharmacology and Toxicology, vol. 18, no. 1, 2017. View at Publisher · View at Google Scholar
  • Jilian Wu, Huiyuan Zhang, Xu Hu, Ruiling Liu, Wei Jiang, Zhonghao Li, and Yuxia Luan, “Reduction-sensitive mixed micelles assembled from amphiphilic prodrugs for self-codelivery of DOX and DTX with synergistic cancer therapy,” Colloids and Surfaces B: Biointerfaces, 2017. View at Publisher · View at Google Scholar
  • Zahra Hami, Seyed Mahdi Rezayat, Kambiz Gilani, Mohsen Amini, and Mahmoud Ghazi-Khansari, “In-vitro cytotoxicity and combination effects of the docetaxel-conjugated and doxorubicin-conjugated poly(lactic acid)-poly(ethylene glycol)-folate-based polymeric micelles in human ovarian cancer cells,” Journal of Pharmacy and Pharmacology, 2017. View at Publisher · View at Google Scholar
  • Saswati Banerjee, Edward P. Acosta, James W. Lillard, Santosh Kumar Singh, and Rajesh Singh, “Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/p21WAF1/CIP1 and p27KIP1 pathway,” Oncotarget, vol. 8, no. 10, pp. 17216–17228, 2017. View at Publisher · View at Google Scholar
  • Mohadeseh Hasanpourghadi, Nazia Abdul Majid, and Mohd Rais Mustafa, “The role of miRNAs 34a, 146a, 320a and 542 in the synergistic anticancer effects of methyl 2-(5-fluoro-2-hydroxyphenyl)-1H- benzo[d]imidazole-5-carboxylate (MBIC) with doxorubicin in breast cancer cells,” PeerJ, vol. 6, pp. e5577, 2018. View at Publisher · View at Google Scholar
  • Audrey F. Adcock, Chiagozie O. Agbai, and Liju Yang, “Application of electric cell-substrate impedance sensing toward personalized anti-cancer therapeutic selection,” Journal of Analytical Science and Technology, vol. 9, no. 1, 2018. View at Publisher · View at Google Scholar
  • Mariya B. Sokol, Elena D. Nikolskaya, Nikita G. Yabbarov, Vladimir A. Zenin, Mariya R. Faustova, Alexey V. Belov, Olga A. Zhunina, Murad D. Mollaev, Artur I. Zabolotsky, Oksana G. Tereshchenko, and Eugen S. Severin, “Development of novel PLGA nanoparticles with co-encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells,” Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2018. View at Publisher · View at Google Scholar
  • Irina A. Tolmacheva, Alexey V. Nazarov, Daria V. Eroshenko, and Victoria V. Grishko, “Synthesis, cytotoxic evaluation, and molecular docking studies of the semi-synthetic “triterpenoid-steroid” hybrids,” Steroids, 2018. View at Publisher · View at Google Scholar
  • Can Özen, Ayşenur Biber, and İpek Z. Durusu, “In vitro anticancer effect of tricyclic antidepressant nortriptyline on multiple myeloma,” Turkish Journal of Biology, vol. 42, no. 5, pp. 414–421, 2018. View at Publisher · View at Google Scholar
  • Shang Eun Park, Kiumars Shamloo, Timothy A. Kristedja, Shaban Darwish, Marco Bisoffi, Keykavous Parang, and Rakesh Kumar Tiwari, “EDB-FN Targeted Peptide–Drug Conjugates for Use against Prostate Cancer,” International Journal of Molecular Sciences, vol. 20, no. 13, pp. 3291, 2019. View at Publisher · View at Google Scholar
  • Jo-Fan Chang, Jui-Ling Hsu, Yi-Hua Sheng, Wohn-Jenn Leu, Chia-Chun Yu, She-Hung Chan, Mei-Ling Chan, Lih-Ching Hsu, Shih-Ping Liu, and Jih-Hwa Guh, “Phosphodiesterase Type 5 (PDE5) Inhibitors Sensitize Topoisomerase II Inhibitors in Killing Prostate Cancer Through PDE5-Independent Impairment of HR and NHEJ DNA Repair Systems,” Frontiers in Oncology, vol. 8, 2019. View at Publisher · View at Google Scholar